<--- Back to Details
First PageDocument Content
Health / Design of experiments / Pharmacology / Drug safety / Pharmaceutical industry / Institutional review board / National Institutes of Health / Public Responsibility in Medicine and Research / Grant / Clinical research / Research / Medicine
Date: 2014-03-10 08:08:08
Health
Design of experiments
Pharmacology
Drug safety
Pharmaceutical industry
Institutional review board
National Institutes of Health
Public Responsibility in Medicine and Research
Grant
Clinical research
Research
Medicine

CONTINUING REVIEW BY THE CONVENED IRB

Add to Reading List

Source URL: ohsr.od.nih.gov

Download Document from Source Website

File Size: 145,16 KB

Share Document on Facebook

Similar Documents

Cell Biology and Cancer under a contract from the National Institutes of Health in collaboration with the National Cancer Institute

DocID: 1vqc4 - View Document

SCIENCE & TECHNOLOGY POLICY IN STITUTE Technology Development at the National Institutes of Health (NIH): Summary Report Brian L. Zuckerman

DocID: 1v9kv - View Document

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Heart, Lung, and Blood Institute (NHLBI)

DocID: 1v3b2 - View Document

Conference Organizers James Prestegard, CFG and University of Georgia Michael Tiemeyer, CFG and University of Georgia John Hanover, CFG and National Institutes of Health Joyce Taylor-Papadimitriou, CFG and King’s Colle

DocID: 1v07l - View Document

Nematode sperm motility* Harold E. Smith§ National Institute for Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD, USA Table of Contents

DocID: 1uVU8 - View Document